Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus
Authors:
Open Access
- 14 July 2015
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 32 (12) , 1568-1574
Abstract
Aims: To analyse blood glucose control according to continuous glucose monitoring use in data from the CareLink™ database, and to identify factors associated with continuation of sensor use during sensor‐augmented pump therapy.Methods: The analysis used data from 10 501 people with Type 1 and 2 diabetes mellitus, of whom 7916 (61.7%) had used glucose sensors for ≥ 15 days during any 6‐month period over a 2‐year observation period. Data were analysed according to the extent of sensor use ( < 25%, 25–49%, 50–74% and ≥ 75% of the time). Time to discontinuation of sensor use was also analysed in new users of glucose sensors.Results: Compared with patients in the lowest sensor usage group and non‐users, the highest glucose sensor usage group had significantly (P < 0.0001) lower mean blood glucose and blood glucose sd, were more likely to achieve a mean blood glucose concentration < 8.6 mmol/l, (odds ratio 1.5, 95% CI 1.3–1.7; P < 0.0001), and had 50% fewer hypoglycaemic (blood glucose concentration < 2.8 mmol/l) episodes. Among new users, sensor use during the first month of therapy was an important predictor of subsequent discontinuation. Lack of full reimbursement was also significantly associated with early discontinuation, whereas measures of glycaemic control were predictive of discontinuation during long‐term treatment.Conclusions: The use of continuous glucose monitoring was significantly associated with reductions in hypoglycaemia and improved metabolic control during insulin pump therapy. Sensor use during the first month was strongly associated with long‐term adherence; patient education and training may be helpful in achieving this.Keywords
Funding Information
- Medtronic International Trading Sarl
- Slovene National Research Agency (J3-6798, J3-4116, P3-0343)
This publication has 25 references indexed in Scilit:
- Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 DiabetesJAMA, 2013
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaNew England Journal of Medicine, 2013
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialDiabetologia, 2012
- Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes MellitusAnnals of Internal Medicine, 2012
- Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) StudyDiabetes Care, 2011
- Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trialDiabetic Medicine, 2011
- Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient dataBMJ, 2011
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 DiabetesDiabetes Care, 2011
- The SWITCH Study (Sensing With Insulin pump Therapy to Control HbA 1c ): Design and Methods of a Randomized Controlled Crossover Trial on Sensor-Augmented Insulin Pump Efficacy in Type 1 Diabetes Suboptimally Controlled with Pump TherapyDiabetes Technology & Therapeutics, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesNew England Journal of Medicine, 2010